Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/15758
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomas, AL-
dc.contributor.authorO'Byrne, K-
dc.contributor.authorFurber, L-
dc.contributor.authorJeffery, K-
dc.contributor.authorSteward, WP-
dc.date.accessioned2012-10-24T09:00:24Z-
dc.date.available2012-10-24T09:00:24Z-
dc.date.issued2001-10-1-
dc.identifier.citationCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (4), pp. 266-268-
dc.identifier.issn0344-5704-
dc.identifier.urihttp://hdl.handle.net/2381/15758-
dc.formatmetadata-
dc.language.isoEnglish-
dc.publisherSPRINGER-VERLAG-
dc.sourceWeb of Science-
dc.source.urihttp://webofknowledge.com-
dc.subjectScience & Technology-
dc.subjectLife Sciences & Biomedicine-
dc.subjectOncology-
dc.subjectPharmacology & Pharmacy-
dc.subjectCaelyx-
dc.subjectliposomal doxorubicin-
dc.subjectphase II-
dc.subjectgastric carcinoma-
dc.subjectOVARIAN-CANCER-
dc.subjectTRACT CANCER-
dc.subjectTRIAL-
dc.subjectFLUOROURACIL-
dc.subjectEPIRUBICIN-
dc.subjectCISPLATIN-
dc.subject5-FLUOROURACIL-
dc.subjectMETHOTREXATE-
dc.titleA phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer-
dc.typeJournal Article-
dc.identifier.doi10.1007/s002800100351-
dc.description.irispid16981-
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.